Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

5 results about "Arteriosclerosis obliterans" patented technology

Arteriosclerosis obliterans is an occlusive arterial disease most prominently affecting the abdominal aorta and the small- and medium-sized arteries of the lower extremities, which may lead to absent dorsalis pedis, posterior tibial, and/or popliteal artery pulses.

Composition for treating lower limb arteriosclerosis obliterans

The invention relates to the technical field of traditional Chinese medicine compositions, and particularly discloses a composition for treating lower limb arteriosclerosis obliterans, which is technically characterized by being prepared from ten medicinal materials, namely red ginseng, astragalus membranaceus, cassia twig, morinda officinalis, cistanche deserticola, salvia miltiorrhiza, pseudo-ginseng, radix cyathulae, sargentgloryvine stem and semen brassicae according to a specific weight part ratio. Aiming at the core pathogenesis of yang deficiency and blood stasis of lower limb arteriosclerosis obliterans, the composition disclosed by the invention provides a treatment method of tonifying qi, warming yang, promoting blood circulation to remove blood stasis, removing speckles and dredging vessels, the compatibility of the whole formula is rigorous, and monarch, minister, assistant and guide are clear; moreover, the composition can be prepared into capsules or granules, is used for treating yang deficiency and blood stasis type lower limb arteriosclerosis obliterans, has an exact clinical curative effect, can remarkably improve symptoms of patients and lower limb blood flow, and is good in safety.
Owner:HUNAN ACAD OF CHINESE MEDICINE

MiRNA-181a-5p and application of miRNA-181a-5p inhibitor in medicine for treating lower limb arteriosclerosis obliterans

The invention relates to the technical field of medicines, in particular to miRNA-181a-5p and application of an inhibitor of miRNA-181a-5p in a medicine for treating lower limb arteriosclerosis obliterans. The research on disease pathogenesis finds that miRNA-181a-5p is particularly important in the occurrence and development process of lower limb arteriosclerosis obliterans, and the miRNA-181a-5p inhibitor is adopted to treat vascular endothelial cells, so that the functions of the vascular endothelial cells can be improved, including improvement of migration and tubular formation of the vascular endothelial cells; the proliferation function is improved; the ROS generation is reduced.
Owner:EIGHTH AFFILIATED HOSPITAL SUN YAT SEN UNIV (SHENZHEN FUTIAN)

Device for preventing pressure sores after interventional operation of lower limb arteriosclerosis obliterans

PendingCN121731078ANursing bedsMechanical engineeringArteriosclerosis obliterans
The invention relates to the technical field of nursing equipment, and discloses lower limb arteriosclerosis obliterans interventional postoperative pressure sore prevention equipment which comprises a bed body, a main support and an auxiliary support are installed on the two sides of the bed body respectively, the top end of the main support extends to the position above the bed body, and a gasket is laid on the surface of the bed body. The two ends of the gasket are connected with the auxiliary support and the main support respectively, the bed body is further provided with a correction sleeve used for positioning the legs of a patient, and the main support is further provided with a driving assembly. By arranging the correcting sleeve, the leg of a postoperative patient can be positioned, the leg of the patient is kept in a straight state, uncomfortable symptoms such as bleeding and hematoma caused by bad postures are avoided, and when the driving assembly is started, the gasket and the correcting sleeve can be driven to move at the same time; while assisting the patient in turning over, the leg of the patient in a side-by-side state is supported, so that long-time compression of osteophysis parts such as a sacrococcygeal region, a heel and a hip is effectively prevented, and the probability of pressure sores is reduced.
Owner:QUZHOU PEOPLES HOSPITAL (QUZHOU CENT HOSPITAL)

A traditional Chinese medicine composition for stopping ulceration and promoting tissue regeneration, its preparation method, medicinal ointment, and its application.

This invention belongs to the field of traditional Chinese medicine technology, specifically relating to a traditional Chinese medicine composition for ulcer repair and tissue regeneration, its preparation method, a traditional Chinese medicine ointment, and its application. The traditional Chinese medicine composition includes the following components: calamine, calcined gypsum, calcined dragon bone, red lead, pearl, camphor, borneol, borax, yellow gelatin, and lanolin. The traditional Chinese medicine composition provided by this invention has the effects of removing necrotic tissue and promoting tissue regeneration, drying dampness and promoting skin growth. It is used to treat vascular-related ulcers such as thromboangiitis obliterans, lower extremity arteriosclerosis obliterans, and lower extremity venous ulcers, and can also treat various chronic and difficult-to-heal ulcers such as bedsores and postoperative wound non-healing, with significant therapeutic effects. This invention also uses specific excipients, namely, utilizing the synergistic effect between refined honey, rosin, and menthol, to prepare an ointment with better permeability and bioavailability.
Owner:GUANGZHOU HOSPITAL OF TRADITIONAL CHINESE MEDICINE

Meridian Soothing Topical Plaster, its Uses, and Preparation Method

This invention belongs to the field of traditional Chinese medicine technology, specifically relating to a topical plaster for relieving pain and irritation, its uses, and preparation method. The traditional Chinese medicine composition is mainly prepared from raw materials such as leeches, scorpions, centipedes, angelica, scrophularia, coix seed, phellodendron bark, honeysuckle, astragalus, and licorice. The plaster of this invention treats deep vein thrombosis of the lower extremities, thrombophlebitis, thromboangiitis obliterans, and arteriosclerosis obliterans of the lower extremities. It is easy to apply, readily penetrates the skin, and is absorbed transdermally for maximum effect. Compared with oral and injectable medications, it has fewer side effects, directly targets the lesion, is absorbed quickly, has immediate effects, a wide range of applications, and no obvious contraindications.
Owner:LUNAN PHARMA GROUP CORPORATION +1